PURE Bioscience Expands Business Strategy with Sales and Marketing Alliance for Long-Lasting, Broad Spectrum SDC Antimicrobial Products
San Diego, CA, Oct. 14, 2009 – PURE Bioscience (NASDAQ: PURE) announced that it has expanded its business strategy through an alliance with the Dallas-based sales and marketing team Richmont...

BioSante Pharmaceuticals and Cell Genesys Announce Completion of Merger
LINCOLNSHIRE, Ill. & SOUTH SAN FRANCISCO, Calif.--Oct. 14, 2009-- BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) and Cell Genesys, Inc. (NASDAQ:CEGE), today announced the successful completion of their...

Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University
TROY, Mich., Oct. 14, 2009-- Somanetics Corporation (Nasdaq: SMTS) today announced that it has signed an Exclusive Sublicense Agreement with Raba Equity Partners II, LLC ("Raba...

Galapagos expands strategic alliance in metabolic disease with Merck & Co., Inc
Mechelen, Belgium 14 October 2009 - Galapagos NV (Euronext: GLPG) announced today that it has expanded its global strategic alliance in metabolic diseases with an affiliate of Merck & Co., Inc to...

VAXIN LAUNCHES JOINT VENTURE WITH ANC BIO IN KOREA
Birmingham, Alabama – October 14, 2009 – Vaxin Inc., an emerging vaccine company today announced that it has entered into a joint venture with South Korean biomedical company, AnC Bio Group to...

GlaxoSmithKline and Prosensa form alliance to fight Duchenne Muscular Dystrophy
Issued: 13 October 2009, London, UK & Leiden, The Netherlands - GlaxoSmithKline (GSK) and Prosensa, the Dutch based biopharmaceutical company focusing on RNA modulating therapeutics, today announced...

KIMBERLY-CLARK ANNOUNCES DEFINITIVE AGREEMENT TO ACQUIRE I-FLOW CORPORATION
DALLAS and LAKE FOREST, Calif., October 9, 2009 – Kimberly-Clark Corporation (NYSE: KMB) and I-Flow Corporation (NASDAQ: IFLO), a leading healthcare company that develops and markets technically...

MDS Announces Agreement to Sell Central Labs Operation to Czura Thornton
TORONTO, October 9, 2009 - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today announced that it has signed an agreement to sell its...

SOLVAY AND HUATAI TO JOINTLY BUILD HYDROGEN PEROXIDE PLANT IN CHINA
October 9, 2009--Solvay today announces that it has struck an agreement with Huatai Group of China to establish a Hydrogen Peroxide joint venture. The joint venture company, Shandong Huatai Interox...

Ipsen acquires exclusive marketing rights of BLI-800 from Braintree for colonic cleansing before colonoscopy
Braintree (Massachusetts, United States) and Paris (France), 9 October 2009 – Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical Group and Braintree...